Geez - it does look like IMU is in this game very seriously.
great to see that they have acknowledged that they need to improve communication with shareholders - a mature company approach.
5 Clinical trials underway - another 4 to start in 2023 - this is the reason for the latest CR no doubt. Getting the cash fast and in a situation where funding was scarce in the rest of the industry. Timing was good.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.045(12.3%) |
Mkt cap ! $70.31M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 31.5¢ | $1.393M | 4.175M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 233415 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 29252 | 1 |
View Market Depth
| Last trade - 15.54pm 22/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |